Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1992 Jun 1;146(11):1977–1987.

Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group.

P W Connelly 1, D R MacLean 1, L Horlick 1, B O'Connor 1, A Petrasovits 1, J A Little 1
PMCID: PMC1490331  PMID: 1596847

Abstract

OBJECTIVE: To report population reference values for blood lipids, to determine the prevalence of lipid risk factors and to assess their association with other risk factors. DESIGN: Population-based cross-sectional surveys. Survey participants were interviewed at home and provided a blood sample at a clinic. All blood lipid analyses were done in the Lipid Research Laboratory, University of Toronto. The laboratory is standardized in the National Heart, Lung Blood Institute-Centres for Disease Control Standardization Program. SETTING: Nine Canadian provinces, from 1986 to 1990. PARTICIPANTS: A probability sample of 26,293 men and women aged 18 to 74 was selected from the health insurance registers for each province. Blood samples were obtained from 16,924 participants who had fasted 8 hours or more. OUTCOME MEASURES: Concentration of total plasma cholesterol, triglycerides and high density lipoprotein (HDL) and low density lipoprotein (LDL) cholesterol in blood samples from fasting participants. MAIN RESULTS: Of the study population, 46% had total plasma cholesterol levels above 5.2 mmol/L, 15% had LDL-cholesterol levels above 4.1 mmol/L, 15% had triglyceride levels above 2.3 mmol/L and 8% had HDL-cholesterol levels below 0.9 mmol/L. Total plasma cholesterol, LDL-cholesterol and triglyceride levels rose with age in men to a maximum in the 45-54 age group; in women there was little change with age up to ages 45 to 54, at which time the level of each of these lipids increased appreciably. The age-standardized prevalence of obesity was positively associated with elevation of total plasma cholesterol. CONCLUSION: The results suggest the need for a multifactorial approach in health promotion efforts to lower blood cholesterol levels and reduce other risk factors in the population. A considerable number of adults were found to be at risk at all ages in both sexes. In the short term, men aged 34 and older and women aged 45 and older might benefit most from prevention programs.

Full text

PDF
1977

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austin M. A. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 1991 Jan-Feb;11(1):2–14. doi: 10.1161/01.atv.11.1.2. [DOI] [PubMed] [Google Scholar]
  2. Bachorik P. S., Walker R. E., Virgil D. G. High-density-lipoprotein cholesterol in heparin-MnCl2 supernates determined with the Dow enzymic method after precipitation of Mn2+ with HCO3-. Clin Chem. 1984 Jun;30(6):839–842. [PubMed] [Google Scholar]
  3. Beaglehole R., LaRosa J. C., Heiss G., Davis C. E., Williams O. D., Tyroler H. A., Rifkind B. M. Serum cholesterol, diet, and the decline in coronary heart disease mortality. Prev Med. 1979 Sep;8(5):538–547. doi: 10.1016/0091-7435(79)90329-3. [DOI] [PubMed] [Google Scholar]
  4. Burke G. L., Sprafka J. M., Folsom A. R., Hahn L. P., Luepker R. V., Blackburn H. Trends in serum cholesterol levels from 1980 to 1987. The Minnesota Heart Survey. N Engl J Med. 1991 Apr 4;324(14):941–946. doi: 10.1056/NEJM199104043241402. [DOI] [PubMed] [Google Scholar]
  5. Castelli W. P. The triglyceride issue: a view from Framingham. Am Heart J. 1986 Aug;112(2):432–437. doi: 10.1016/0002-8703(86)90296-6. [DOI] [PubMed] [Google Scholar]
  6. Castelli W. P., Wilson P. W., Levy D., Anderson K. Cardiovascular risk factors in the elderly. Am J Cardiol. 1989 May 2;63(16):12H–19H. doi: 10.1016/0002-9149(89)90110-0. [DOI] [PubMed] [Google Scholar]
  7. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  8. Gordon D. J., Knoke J., Probstfield J. L., Superko R., Tyroler H. A. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. Circulation. 1986 Dec;74(6):1217–1225. doi: 10.1161/01.cir.74.6.1217. [DOI] [PubMed] [Google Scholar]
  9. Gordon D. J., Probstfield J. L., Garrison R. J., Neaton J. D., Castelli W. P., Knoke J. D., Jacobs D. R., Jr, Bangdiwala S., Tyroler H. A. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989 Jan;79(1):8–15. doi: 10.1161/01.cir.79.1.8. [DOI] [PubMed] [Google Scholar]
  10. Gordon D. J., Rifkind B. M. High-density lipoprotein--the clinical implications of recent studies. N Engl J Med. 1989 Nov 9;321(19):1311–1316. doi: 10.1056/NEJM198911093211907. [DOI] [PubMed] [Google Scholar]
  11. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  12. Grundy S. M. George Lyman Duff Memorial Lecture. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease. Arterioscler Thromb. 1991 Nov-Dec;11(6):1619–1635. doi: 10.1161/01.atv.11.6.1619. [DOI] [PubMed] [Google Scholar]
  13. Hewitt D., Jones G. J., Godin G. J., McComb K., Breckenridge W. C., Little J. A., Steiner G., Mishkel M. A., Baillie J. H., Martin R. H. Normative standards of plasma cholesterol and triglyceride concentrations in Canadians of working age. Can Med Assoc J. 1977 Nov 5;117(9):1020–1024. [PMC free article] [PubMed] [Google Scholar]
  14. Jacobs D. R., Jr, Mebane I. L., Bangdiwala S. I., Criqui M. H., Tyroler H. A. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol. 1990 Jan;131(1):32–47. doi: 10.1093/oxfordjournals.aje.a115483. [DOI] [PubMed] [Google Scholar]
  15. Jones G. J., Hewitt D., Godin G. J., Breckenridge W. C., Bird J., Mishkel M. A., Steiner G., Little J. A. Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population. Can Med Assoc J. 1980 Jan 12;122(1):37-8, 40-6. [PMC free article] [PubMed] [Google Scholar]
  16. Kalsbeek W. D., Kral K. M., Wallace R. B., Rifkind B. M. Comparing mean levels of total cholesterol from visit 2 of the Lipid Research Clinics Prevalence Study with the second National Health and Nutrition Examination Survey. Am J Epidemiol. 1988 Nov;128(5):1038–1053. doi: 10.1093/oxfordjournals.aje.a115048. [DOI] [PubMed] [Google Scholar]
  17. Kottke T. E., Puska P., Salonen J. T., Tuomilehto J., Nissinen A. Projected effects of high-risk versus population-based prevention strategies in coronary heart disease. Am J Epidemiol. 1985 May;121(5):697–704. doi: 10.1093/aje/121.5.697. [DOI] [PubMed] [Google Scholar]
  18. Kritchevsky D. Age-related changes in lipid metabolism. Proc Soc Exp Biol Med. 1980 Nov;165(2):193–199. doi: 10.3181/00379727-165-40957. [DOI] [PubMed] [Google Scholar]
  19. Levy D., Wilson P. W., Anderson K. M., Castelli W. P. Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study. Am Heart J. 1990 Mar;119(3 Pt 2):712–717. doi: 10.1016/s0002-8703(05)80050-x. [DOI] [PubMed] [Google Scholar]
  20. Linn S., Fulwood R., Rifkind B., Carroll M., Muesing R., Williams O. D., Johnson C. High density lipoprotein cholesterol levels among US adults by selected demographic and socioeconomic variables. The Second National Health and Nutrition Examination Survey 1976-1980. Am J Epidemiol. 1989 Feb;129(2):281–294. doi: 10.1093/oxfordjournals.aje.a115133. [DOI] [PubMed] [Google Scholar]
  21. Little J. A., Horlick L. Consensus reports: implications for the management of hypercholesterolemia and for future research. CMAJ. 1989 Feb 15;140(4):369–370. [PMC free article] [PubMed] [Google Scholar]
  22. Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) 1981 Jun 6;282(6279):1847–1851. doi: 10.1136/bmj.282.6279.1847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Stamler J., Wentworth D., Neaton J. D. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986 Nov 28;256(20):2823–2828. [PubMed] [Google Scholar]
  24. Streja D. A., Marliss E. B., Steiner G. The effects of prolonged fasting on plasma triglyceride kinetics in man. Metabolism. 1977 May;26(5):505–516. doi: 10.1016/0026-0495(77)90094-4. [DOI] [PubMed] [Google Scholar]
  25. Sytkowski P. A., Kannel W. B., D'Agostino R. B. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med. 1990 Jun 7;322(23):1635–1641. doi: 10.1056/NEJM199006073222304. [DOI] [PubMed] [Google Scholar]
  26. Tsevat J., Weinstein M. C., Williams L. W., Tosteson A. N., Goldman L. Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation. 1991 Apr;83(4):1194–1201. doi: 10.1161/01.cir.83.4.1194. [DOI] [PubMed] [Google Scholar]
  27. Tyroler H. A. Total serum cholesterol and ischemic heart disease risk in clinical trials and observational studies. Am J Prev Med. 1985 Jul-Aug;1(4):18–24. [PubMed] [Google Scholar]
  28. Wilson P. W., Abbott R. D., Castelli W. P. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis. 1988 Nov-Dec;8(6):737–741. doi: 10.1161/01.atv.8.6.737. [DOI] [PubMed] [Google Scholar]
  29. Wilson P. W., Garrison R. J., Abbott R. D., Castelli W. P. Factors associated with lipoprotein cholesterol levels. The Framingham study. Arteriosclerosis. 1983 May-Jun;3(3):273–281. doi: 10.1161/01.atv.3.3.273. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES